Microfluidics Market to Reach $37.2 Billion by 2030
The global microfluidics market is projected to grow from USD 24.96 billion in 2025 to USD 37.2 billion by 2030, at a CAGR of 8.3% during the forecast period. Market growth is being driven by the increasing adoption of point-of-care (PoC) diagnostics, advancements in biotechnology, and expanding applications in drug delivery systems.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1305
Microfluidic...
Recombinant Proteins Market Growth, Trends, and Forecast 2028: Driving Innovation in Biologics and Precision Medicine
The global recombinant proteins market is witnessing significant growth as advancements in biotechnology, increasing demand for biologics, and rising focus on personalized medicine reshape the healthcare landscape. The market was valued at USD 2.2 billion in 2023 and is projected to reach USD 3.2 billion by 2028, growing at a CAGR of 7.2% during the forecast period from 2023 to 2028.
The expanding...
Biopharmaceutical Contract Manufacturing Market: Accelerating Innovation, Scale, and Global Biologics Supply
The global biopharmaceutical contract manufacturing market is undergoing a powerful transformation, driven by the rapid expansion of biologics, increasing demand for personalized therapies, and the growing reliance on specialized outsourcing partners. Valued at USD 22.40 billion in 2025, the market is projected to grow at a strong CAGR of 8.8% over the forecast period, reflecting its critical role...
Single-Use Bioprocessing Market: Driving Efficiency and Flexibility in Biopharmaceutical Manufacturing
The biopharmaceutical industry is undergoing a rapid transformation, with manufacturers increasingly seeking flexible, cost-effective, and scalable production solutions. At the forefront of this shift is the Single-Use Bioprocessing Market, which is redefining how biologics, vaccines, and advanced therapies are developed and manufactured.
The market is projected to grow from USD 18.01 billion in...
Organ-on-Chip Market Set to Reach US$631.1 Million by 2029 Amid Rising Demand for Animal-Free Drug Testing
The global organ-on-chip market is witnessing remarkable growth as pharmaceutical and biotechnology companies increasingly adopt advanced alternatives to traditional animal testing models. Valued at US$89.2 million in 2023, the market expanded to US$123.3 million in 2024 and is projected to grow at an impressive CAGR of 38.6% from 2024 to 2029, ultimately reaching US$631.1 million by 2029.
The...
Organ-on-Chip Market Set to Reach US$631.1 Million by 2029 Amid Rising Demand for Animal-Free Drug Testing
The global organ-on-chip market is witnessing remarkable growth as pharmaceutical and biotechnology companies increasingly adopt advanced alternatives to traditional animal testing models. Valued at US$89.2 million in 2023, the market expanded to US$123.3 million in 2024 and is projected to grow at an impressive CAGR of 38.6% from 2024 to 2029, ultimately reaching US$631.1 million by 2029.
The...
Cell Culture Equipment :Fueled by Growth in Biopharmaceutical Production and Cell-Based Therapies
The global cell culture equipment market is projected to grow from USD 8,368.0 million in 2026 to USD 14,187.6 million by 2031, registering a CAGR of 11.1% during the forecast period. The market is witnessing strong momentum, driven by the increasing adoption of cell culture-based therapies, rising production of monoclonal antibodies, and expanding applications in regenerative medicine and...
Immunohistochemistry: Driven by Rising Cancer Diagnostics and Adoption of Standardized Kits
The global Immunohistochemistry (IHC) Market is projected to grow from USD 3.55 billion in 2025 to USD 5.14 billion by 2030, registering a CAGR of 7.6% during the forecast period. Growth is primarily driven by increasing cancer incidence, expanding diagnostic applications, and the rising need for accurate, biomarker-based disease identification.
Browse
794 ...
Oligonucleotide CDMO Market to Hit US$6.73 Billion by 2029 with 21.8% CAGR | Growth and outlook
The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, reaching US$2.51 billion in 2024 and an impressive US$6.73 billion by 2029. Rising outsourcing of development and manufacturing to CDMOs and growing focus on precision/personalized medicine are some of the factors driving the market’s...